Jaymes Holland
Alaunos Therapeutics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jaymes Holland as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04006119 · Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive GlioblastomaAlaunos Therapeutics · terminated · Glioblastoma · study director
- Ph1NCT03679754 · Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102Alaunos Therapeutics · completed · Glioblastoma · study director
- Ph1NCT03636477 · A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102Alaunos Therapeutics · completed · Glioblastoma · study director
- Ph1/Ph2NCT03330197 · A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGAlaunos Therapeutics · terminated · Pediatric Brain Tumor, Diffuse Intrinsic Pontine Glioma · study director
- Ph1/Ph2NCT02423902 · A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerAlaunos Therapeutics · terminated · Metastatic Breast Cancer · study director
- Ph1NCT02026271 · A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant GliomaAlaunos Therapeutics · completed · Glioblastoma Multiforme, Anaplastic Oligoastrocytoma · study director
- Ph2NCT01703754 · Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.Alaunos Therapeutics · terminated · Breast Cancer Nos Metastatic Recurrent · study director
- Ph1/Ph2NCT01397708 · Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat MelanomaAlaunos Therapeutics · completed · Melanoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).